Poland· PL-100219451
InductOs
A dibotermin alfa product containing diboterminum alfa, registered in Poland by Medtronic BioPharma B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dibotermin alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC M05BC01 (dibotermin alfa), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Dibotermin alfa · ATC M05BC01
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Diboterminum alfa
- Manufacturer
- Medtronic BioPharma B.V.
- Country
- Poland (PL)
- ATC code
- M05BC01
- ATC class
- Dibotermin alfa
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990009763
- gtin05909990746187
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibotermin alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumInductOs 1.5 mg/mlMedtronic Biopharma
- SwitzerlandInductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantationMedtronic BioPharma Sàrl
- SpainINDUCTOS 1,5 MG/ML POLVO, DISOLVENTE Y MATRIZ PARA MATRIZ DE IMPLANTACIÓNMedtronic Biopharma B.V.
- NorwayInductOsMedTronic BioPharma B.V.
- SwedenInductOs 1,5 mg/ml Pulver, vätska och matrix till matrix för implantationMedtronic BioPharma B.V.
- United KingdomInductOs 12mg powder and solvent and matrix for implantation matrixMedtronic Ltd
- FinlandInductosMedtronic BioPharma B. V.
- CzechiaINDUCTOSMedtronic BioPharma B.V., Heerlen
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inductos
- Liechtenstein · Inductos
- Norway · Inductos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20130404-3a8b-464d-914f-75e24bc9818f GET /v1/drugs/20130404-3a8b-464d-914f-75e24bc9818f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek, rozpuszczalnik i matryca do sporządzania matrycy do implantacji",
"source": "urpl",
"strength": "1,5 mg/ml",
"packaging": "05909990746187 ¦ Rpz ¦ EU/1/02/226/001 ¦ 54586\n1 fiol. 12 mg proszku ¦ 1 fiol. 10 ml rozp. + 1 podłoże + 2 strzykawki + 2 igły\n05909990009763 ¦ Rpz ¦ Skasowane ¦ EU/1/01/226/001 ¦ 107005\n1 zestaw \nRpz ¦ EU/1/02/226/002 ¦ 126046\n1 fiol. 4 mg proszku ¦ 1 fiol. 10 ml rozp. + + 2 podłoża + 2 strzykawki + 2 igły",
"substance": "Diboterminum alfa 12 mg",
"common_name": "Diboterminum alfa",
"pl_product_id": "100219451",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about dibotermin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.